Philip Shapira

Philip Shapira is a Part-Time Professor at the Jimmy and Rosalynn Carter School of Public Policy, Georgia Institute of Technology, and a Professor of Management, Innovation and Policy at the Manchester Institute of Innovation Research, University of Manchester. His work focuses on science and technology policy, innovation systems, and responsible research and innovation. Shapira holds a Ph.D. from UC Berkeley in City and Regional Planning, an M.A. in Economics, an M.C.P. from MIT in City Planning, and a Dip.TP from Gloucestershire College of Art and Design. He directs the Georgia Tech Program in Science, Technology, and Innovation Policy and the Georgia Manufacturing Survey. His research spans nanotechnology, synthetic biology, and AI ethics, with recent emphasis on generative AI’s impact on scientific publishing. Shapira is a Fellow of the AAAS and RSA, and co-edited key handbooks on innovation policy.

Research Interests: Shapira’s work bridges policy and practice, analyzing how innovation systems drive economic development while addressing societal challenges. Key areas include:

• Technology trajectories and policy evaluation
• Responsible innovation in emerging fields like synthetic biology
• AI ethics and academic integrity
• Manufacturing competitiveness and equity

Articles Trends: Recent publications examine generative AI’s role in scientific writing, societal alignment in innovation, and bioeconomy strategies. His 2024 work on ChatGPT’s influence on academic prose highlights methodological innovations in detecting AI-generated text.

Awards: Recognized for contributions to science policy, Shapira’s fellowships underscore his dual focus on scholarly rigor and public engagement.

Advising & Grants: Leads initiatives like the Georgia Manufacturing Survey and collaborates on EU-funded open innovation networks. Current projects include analyzing AI’s impact on science and designing tools for rapid sustainability assessment in biotechnology.

Labs/Teams: Associated with the Technology Policy and Assessment Center at Georgia Tech and SYNBIOCHEM (Manchester), focusing on biofoundries and translational research.